Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003507210 | SCV004326949 | pathogenic | Holoprosencephaly 5 | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 258 of the ZIC2 protein (p.Cys258Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with holoprosencephaly (Invitae). In at least one individual the variant was observed to be de novo. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ZIC2 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |